Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The atypical antipsychotic risperidone significantly raises plasma prolactin levels in patients, but clozapine, olanzapine, and quetiapine do not. The differences in neuroendocrine response may be connected with the metabolism of the medications. The authors examined the contributory role of risperidone's active metabolite 9-hydroxy-risperidone by measuring plasma concentrations of risperidone, 9-hydroxy-risperidone, and prolactin. METHOD: Blood samples taken from 25 patients with psychotic disorders following 6 weeks of treatment with risperidone (mean dose=3 mg/day) were examined. Mean plasma concentrations of risperidone, 9-hydroxy-risperidone, and prolactin were 4.6, 19.4, and 49.3 ng/ml, respectively. RESULTS: The oral dose of risperidone correlated significantly with plasma concentrations of risperidone, 9-hydroxy-risperidone, active moiety, and prolactin. The plasma concentration of 9-hydroxy-risperidone, but not of risperidone, correlated significantly with increases in plasma prolactin. CONCLUSIONS: These data suggest that the 9-hydroxy metabolite plays a predominant role in risperidone's effect on prolactin release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prolactin and dopamine: What is the connection? A Review Article
Fitzgerald, P., & Dinan, T. G. (2008) · Journal of Psychopharmacology · doi:10.1177/0269216307087148 · Cited by 383
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350
Paliperidone for schizophrenia
Dolder, C., Nelson, M., & Deyo, Z. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070261 · Cited by 254
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4e5 · Cited by 153
“Because the pituitary gland lies outside the blood-brain barrier, it is reasonable to suspect that compounds with high dopamine-receptor affinity and low brain-barrier penetrability may have more pronounced effects on prolactin levels despite their antagonism of serotonin receptors.(176) The final hypothesis suggests…”
BackgroundKnegtering, H., Boks, M., Blijd, C., Castelein, S., van den Bosch, R. J., & Wiersma, D. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600666378 · Cited by 74
“On the other hand, the findings of this prospective open-label randomized study of olanzapine and risperidone are consistent with prior studies and case reports of hyperprolactinemia occurring in risperidone-treated patients (Chung & Eun, 1998; Claus et al., 2002; Dickson, Dalby, Williams, & Edwards, 1995; Kearns, Gof…”
ResultSelf-citation
Metadata
- Authors
- Knegtering, R., Baselmans, P., Castelein, S., Bosker, F., Bruggeman, R., & van den Bosch, R. J.
- Venue
- American Journal of Psychiatry
- Published
- 2005-05-01
- Volume
- 162
- Issue
- 5
- Pages
- 1010-1012
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2108450329
- Cited by
- 150
- References
- 0
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels. https://app.cochat.ai/papers/10.1176/appi.ajp.162.5.1010
- The paper
- Knegtering, R., Baselmans, P., Castelein, S., Bosker, F., Bruggeman, R., & van den Bosch, R. J. (2005). Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.162.5.1010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.